NCT00674804

Communicating a Cancer Diagnosis-Current Methods and Their Effects

Communicating a Cancer Diagnosis: Current Methods and Their Effects

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,100 (planned)
• Sponsor: National Institutes of Health Clinical Center (CC) · NIH
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will: * Distinguish methods of telling the diagnosis and identify its relationship to the type of cancer. * Determine if the way a patient is informed of their diagnosis is associated with their level of satisfaction with the method of being informed. * Identify who informs the patient of their diagnosis.. * Determine patient satisfaction with their diagnostic consult. * Identify indicators of satisfaction with the diagnostic consultation. Patients 18 years of age or older who are enrolled in or being screened for enrollment in a phase I, II or III clinical trial in the National Cancer Institute's Medical Oncology, Metabolism, Surgery or Neuro-Oncology branch may be eligible for this study. Participants complete a 15-minute questionnaire that includes questions related to the how they were informed of their cancer diagnosis.

Detailed description

Background: \- The goals of the study are to identify how a patient with a diagnosis of cancer is informed of their condition and to illuminate the way in which this information exchange occurs. Objectives: To distinguish, identify and determine: * If the method by which a patient is informed of a diagnosis of cancer is associated with their level of satisfaction with that method of being informed * Who tells the patient of their condition * The methods used to inform a patient of their condition * Prognostic indicators of high satisfaction within the diagnostic consult Eligibility: * Patients currently enrolled or being screened for enrollment for a phase I, II or III clinical trial at the National Cancer Institutes clinic center- specifically, within the following branch clinics: Medical Oncology, Metabolism, Surgery and Neuro-Oncology. * Patient must be 18 years or older and be willing to participate in the study. Design: * Primary methodological practice is a self-administered questionnaire. * Questionnaire to be completed by patient on same day that it is administered at NCI.

Conditions

• Behavior
• Cancer

Timeline

• Start date: 2008-04-24
• Primary completion: 2009-07-16
• Completion: 2009-07-16
• First posted: 2008-05-08
• Last updated: 2017-07-02

Locations

1 site across 1 country: United States